PTCT - PTC Therapeutics Inc
IEX Last Trade
35.27
-0.260 -0.737%
Share volume: 334,064
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$35.53
-0.26
-0.73%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-04 | 2022-10-27 | 2023-02-21 | 2023-04-27 | 2023-08-03 | 2023-10-26 | 2024-02-29 | 2024-04-25 | |
| Total revenue | 165.526 M | 217.127 M | 167.413 M | 220.382 M | 213.808 M | 196.576 M | 307.056 M | 210.118 M | |
| Cost of revenue | 9.639 M | 14.011 M | 10.893 M | 14.144 M | 12.731 M | 9.493 M | 29.118 M | 14.740 M | |
| Gross profit | 155.887 M | 203.116 M | 156.520 M | 206.238 M | 201.077 M | 187.083 M | 277.938 M | 195.378 M | |
| 30.30% | -22.94% | 31.76% | -2.50% | -6.96% | 48.56% | -29.70% | |||
| Operating expenses | 237.155 M | 245.580 M | 281.410 M | 282.038 M | 274.323 M | 245.098 M | 197.644 M | 189.401 M | |
| Selling general and admin | 79.892 M | 80.118 M | 92.717 M | 86.914 M | 88.449 M | 80.886 M | 76.291 M | 73.272 M | |
| Research and development | 157.263 M | 165.462 M | 188.693 M | 195.124 M | 185.874 M | 164.212 M | 121.353 M | 116.129 M | |
| Total expenses | 273.088 M | 290.614 M | 328.067 M | 335.597 M | 334.451 M | 313.240 M | 303.936 M | 255.671 M | |
| 6.42% | 12.89% | 2.30% | -0.34% | -6.34% | -2.97% | -15.88% | |||
| Operating income | -107.562 M | -73.487 M | -160.654 M | -115.215 M | -120.643 M | -116.664 M | 3.120 M | -45.553 M | |
| Ebit | -107.562 M | -73.487 M | -160.654 M | -115.215 M | -120.643 M | -116.664 M | 3.120 M | -45.553 M | |
| Pretax income | -148.695 M | -127.208 M | -189.693 M | -134.990 M | -237.479 M | -166.590 M | -157.051 M | -84.696 M | |
| -14.45% | 49.12% | -28.84% | 75.92% | -29.85% | -5.73% | -46.07% | |||
| Income tax | 3.392 M | -17.893 M | -18.804 M | 3.969 M | -38.596 M | -33.620 M | -1.259 M | 6.880 M | |
| Net income basic | -152.087 M | -109.315 M | -170.889 M | -138.959 M | -198.883 M | -132.970 M | -155.792 M | -91.576 M | |
| 28.12% | -56.33% | 18.68% | -43.12% | 33.14% | -17.16% | 41.22% | |||
| Net income | -152.087 M | -109.315 M | -170.889 M | -138.959 M | -198.883 M | -132.970 M | -155.792 M | -91.576 M | |
| 28.12% | -56.33% | 18.68% | -43.12% | 33.14% | -17.16% | 41.22% |